Zelira Therapeutics is a leading global biopharmaceutical company developing and marketing customised medicines uniquely formulated to target unmet patient needs.
Zelira Therapeutics has developed several pharmaceutical-grade cannabinoid-based medicines that are currently available in Australia and the USA.
We are committed to research and clinical development including:
Accessing Medicinal Cannabis in Australia
Medicinal Cannabis is a Prescription Medicine
Medicinal cannabis is available to patients like other prescription medicines, on written authorisation from a registered medical professional.
Any registered medical doctor in Australia can prescribe medicinal cannabis, if the doctor makes an evidence-based judgement that this is the appropriate treatment for their patient. The doctor will consider the patient’s symptoms, family history, and the other treatments that have been tried, in making this judgement.
Like any other prescription, Zelira’s medicines can be dispensed by any pharmacy Australia-wide, with delivery available to most Australian locations within 24 hours.
We suggest the following steps
How to prescribe…
- Any medical practitioner can apply for medicinal cannabis via an SAS B application – you do not have to be an Authorised Prescriber, have a special license or have a formal training.
- Since the TGA have streamlined the process of SAS B applications it can take as little as 10-15 minutes to apply.
- Zelira has developed a step-by-step guide to assist doctors with the application process. The guide can be accessed in the “Doctors” portal of our website or to speak to one of Zelira’s dedicated staff just use the phone number below during business hours.
Medicinal Cannabis PrescriptionsIn Australia the number of medical practitioners prescribing medicinal cannabis is increasing:
|SAS category B applications approved by the TGA for medicinal cannabis products (at 6 September 2021)1|
|Medical practitioners have gained approval to prescribe Medicinal Cannabis (at 6 September 2021)1|
|Authorised Prescribers for medicinal Cannabis in Australia (at 31 July 2021)2|